Femibion Grossesse Metafolin+DHA
Food supplement declared in France, declaration No 2019-9-178, decision dated 6 September 2019
Femibion Grossesse Metafolin+DHA, from P&G Health France SAS, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Pantothenic acid (vitamin B5), Biotin (vitamin B8), Iron, Folate (vitamin B9), Iodine. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- P&G Health France SAS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Autre : Comprimé + capsule
- Daily dose
- 1 comprimé + 1 capsule
- Directions for use
- A avaler avec un verre d'eau
- Objectives stated by the manufacturer (these are not authorised claims)
- Pregnancy and breastfeeding
Declaration 165438, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Huile de poisson | not declared |
| Lutéine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothenate, calcium | Pantothenic acid (vitamin B5) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-biotin | Biotin (vitamin B8) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| ferrous bisglycinate | Iron | 40 mg (safe level) | 14 mg |
| calcium-L-methylfolate | Folate (vitamin B9) | 1,000 µg | 200 µg |
| pteroylmonoglutamic acid | Folate (vitamin B9) | 1,000 µg | 200 µg |
| potassium iodide | Iodine | 600 µg | 150 µg |
| magnesium oxide | Magnesium | 250 mg | 300 mg |
| nicotinamide | Nicotinamide (vitamin B3) | 900 mg | 54 mg |
| sodium selenate | Selenium | 255 µg | 50 µg |
| thiamin mononitrate | Vitamin B1 (thiamine) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| cyanocobalamin | Vitamin B12 | no adverse effect defined | dose annulled by the French Council of State in 2011 |
| riboflavin | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
| calcium-L-ascorbate | Vitamin C | no limit (insufficient data) | 180 mg |
| cholecalciferol | Vitamin D | 100 µg (4,000 IU) | 5 µg (200 IU) |
| DL-alpha-tocopheryl acetate | Vitamin E | 300 mg | 30 mg |
| zinc oxide | Zinc | 25 mg | 15 mg |
Additives
E460, E464, E170, E468, E330, E1203, E1521, E463, E553b, E470b, E570, E341, E1450, E422, E471, E306, E322
Other ingredients
maltodextrine, saccharose, amidon, Gélatine de poisson, Huile de carthame
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
En cas de troubles de la thyroïde demandez conseil à votre médecin.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Femibion Grossesse Metafolin+DHA MERCK MEDICATION FAMILIALE, declared in 2019, withdrawn from the market : different composition: 10 ingredient(s) added, 16 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Femibion Grossesse Metafolin+DHA: composition and regulation”, https://compoatlas.com/en/supplements/products/165438-femibion-grossesse-metafolin-dha, updated 15 November 2026.